Finance Pharmaceuticals Power Process 
Harvard Business Review
JULY 17, 2014
But the real power and full potential of data was not being fully realized by marketing. Rajamannar involved finance early. To spearhead analytic efforts, he assigned a finance person – who was already embedded in marketing – to create an ROI evaluation framework and integrated her deeper into the marketing function.
Harvard Business Review
NOVEMBER 10, 2017
Learning needs to be built into how power really works within organizations, organized around peer power, functional power, and hierarchical power. In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
APRIL 2, 2018
There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations.
Harvard Business Review
MARCH 14, 2017
In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.
Harvard Business Review
FEBRUARY 4, 2013
Most of us would say it's exceptionally hard, particularly when power is concentrated in a few incumbent companies with deeply rooted vested interests. But this focused power may be a benefit, not a risk. For example, the rapidly evolving field of biomimicry examines nature's models and processes to help solve human problems.
Harvard Business Review
MAY 15, 2013
It also focuses our attention on the forces that shape behavior in organizations, and so highlights an important question: are all those forces (including structure, processes, and incentives) "culture" or is culture simply the behavioral outputs? "In Culture is a process of "sense-making" in organizations.
Harvard Business Review
SEPTEMBER 4, 2015
However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.
Expert insights. Personalized for you.
13 
Let's personalize your content